Aligos Therapeutics

0 followers

‌

Aligos Therapeutics is discovering and developing new classes of compounds that interact directly with disease causing molecules.

Industries

Biotechnology

Headquarters

South San Francisco, United States

Employees

51-200

Links

Org chart

Lawrence M. Blatt

Chairman & CEO

Lawrence M. Blatt

Collapse

Lesley Ann Calhoun

EVP & CFO

Lucinda Y. Quan

EVP, Chief Business Officer & General Counsel

Julian A. Symons

EVP & Chief Scientific Officer

Dave Smith

Executive Vice President

Tse-I Lin

VP, Early Compound Development & Belgian Site Head

Kristina Engeseth

VP & Head, People & Culture

Dinah Misner

Vice President

Hardean E. Achneck

Chief Medical Officer

Teams

+12

Research and Development Scientists

15 members

Leadership Team

6 members

Operations and Management

7 members

Similar companies

SpringWorks Therapeutics

5 followers

REVOLUTION Medicines

5 followers

Kymera Therapeutics

5 followers

Stemline Therapeutics

3 followers

Prime Medicine

3 followers

Tenaya Therapeutics

2 followers

Modern Meadow

2 followers

Vividion Therapeutics

1 follower

ReCode Therapeutics

1 follower

Embark Veterinary

1 follower

Dragonfly Therapeutics

1 follower

Explore companies